Stock KURN KUROS BIOSCIENCES AG
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Kuros Biosciences AG

Equities

KURN

CH0325814116

Market Closed - Swiss Exchange
Other stock markets
 11:30:41 2024-04-29 EDT 		5-day change 1st Jan Change
6.4 CHF -6.71% Intraday chart for Kuros Biosciences AG -21.18% +83.38%
04-24 Kuros Biosciences Posts Higher Q1 Product Sales MT
04-17 Kuros Biosciences AG Approves Board of Director and Committee Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bourse Zurich: retour dans le rouge, Roche plombe l'indice
Les ventes de Kuros s'envolent
Kuros mit erneut starkem Umsatz- und Ergebnissprung im ersten Quartal
Kuros Biosciences Posts Higher Q1 Product Sales
Kuros Biosciences AG Approves Board of Director and Committee Changes
Bourse Zurich: le SMI poursuit sa progression, nouveau plus haut de l'année
Bourse Zurich: les indices passent l'épaule en fin de matinée
Kuros Biosciences' FY23 Attributable Loss Shrinks; Revenue Up
Kuros toujours dans le rouge en 2023 malgré des recettes plus que doublées
Kuros hat nach Umsatzsprung den Verlust verringert
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2023
Bourse Zurich: dans le rouge avant la Fed, Novartis pèse sur le SMI
US FDA Approves Kuros Biosciences' Bone Graft Granules for Interbody Use
Kuros: nouvelles autorisations pour Magnetos aux USA et en Nouvelle-Zélande
Kuros erhält weitere Zulassung für MagnetOs in den USA und Neuseeland
Kuros Biosciences Receives US FDA 510K Clearance for Magnetos Granules for Interbody Use and Regulatory Clearance of Magnetos Granules and Magnetos Putty in New Zealand
Kuros stellt neue Daten vor und erhält zwei weitere FDA-Zulassungen
Kuros obtient deux nouvelles autorisations de la FDA et avance sur Magnetos
Kuros Biosciences Announces Three Advancements Related to its MagnetOs Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
Aktien Schweiz nach Weihnachtspause etwas leichter
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KURN Stock
  4. News Kuros Biosciences AG
  5. Other languages